FOR LABORATORY RESEARCH PURPOSES ONLY. This compound has not received FDA approval. All information shown is drawn from published laboratory research for educational purposes
$250.00
Lost, stolen, or damaged? We replace it, on us.
Pick your speed at checkout.
Before you continue
This site sells research products exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
Slimetry Capsules (26.15mg) are a two-compound research formulation containing 5-Amino-1MQ and BPC-157, supplied in capsule form for laboratory research use only. This page summarises what the formulation contains; batch-specific analytical data is shown in the sections below.
Slimetry Capsules combine two separately characterised research compounds in one capsule format. Pairing a small molecule with a peptide in a single format gives laboratories one defined source material containing both compounds.
Slimetry Capsules are supplied for laboratories that wish to examine 5-Amino-1MQ and BPC-157 together within their own in vitro research designs. Each component has its own body of published laboratory literature, which researchers should consult directly when planning a study. The capsule is a supply format only; this page makes no statement about how the formulation behaves in any biological system.
Each batch contains 5-Amino-1MQ and BPC-157. The identity of both components is shown in the Product Specifications section.
Slimetry Capsules are supplied as capsules, with a stated content of 26.15mg.
For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. This compound has not received FDA approval. All information shown is drawn from clinical studies for educational purposes.
Researcher favourites
Price range: $125.00 through $175.00
Price range: $150.00 through $650.00
Price range: $125.00 through $700.00
$150.00
$175.00
Lab-verified quality
Each lot is analysed by Bioviridian before release. Below is the Certificate of Analysis for the most recent lot, as issued by the laboratory.
Overall purity
99.7%
RP-HPLC (214 nm)
View the signed COA (PDF)Check this certificate at bioviridians.com/coa-search.html with code COA7700.
Test results
5 of 5 conformHPLC retention time 2.465, 9.242 min · Signed: Shane Straight, M.S., Principal Chemist, Bioviridian Inc.
Every lot keeps its own signed certificate. Lots are listed newest first.
Lot SLIMCAP7-2026
99.7%
Overall purity
Tested July 13, 2026
Open COAEarlier lots will appear here as new Certificates of Analysis are published.
Compound details
Molecular profile
Storage requirements
Storage guidance is provided with the product.
Published literature
4 peer-reviewed publications indexed on PubMed. Listed for reference only; inclusion does not imply any use, effect or endorsement.
JOURNAL OF MEDICINAL CHEMISTRY · 2017 5-Amino-1MQ
Structure-Activity Relationship for Small Molecule Inhibitors of Nicotinamide N-Methyltransferase
Neelakantan H, Wang HY, Vance V, et al. Journal of medicinal chemistry. 2017;60(12):5015-5028. doi:10.1021/acs.jmedchem.7b00389
Screened N-methylated quinolinium and related scaffolds against recombinant NNMT to build structure-activity relationships, with docking of inhibitors into the enzyme's substrate-binding site.
CURR PHARM DES · 2014 BPC-157
Seiwerth S, Brcic L, Vuletic LB, et al. Curr Pharm Des. 2014;20(7):1121-5. doi:10.2174/13816128113199990421
Reviewed published laboratory and preclinical research on BPC 157 in relation to blood-vessel biology.
CURR PHARM DES · 2014 BPC-157
Stable gastric pentadecapeptide BPC 157-NO-system relation
Sikiric P, Seiwerth S, Rucman R, et al. Curr Pharm Des. 2014;20(7):1126-35. doi:10.2174/13816128113190990411
Reviewed research on the relationship between BPC 157 and the nitric oxide (NO) system.
NEURAL REGEN RES · 2022 BPC-157
Pentadecapeptide BPC 157 and the central nervous system
Vukojevic J, Milavić M, Perović D, et al. Neural Regen Res. 2022;17(3):482-487. doi:10.4103/1673-5374.320969
Reviewed preclinical research on BPC 157 in relation to the central nervous system.
